OLN FY2025 SEC EDGAR DEF 14A #42 of 168 in industry

OLIN Corp CEO pay ratio

The CEO earned $9.8M in FY2025 against median worker pay of $98,383 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
VA
Filing date
2026-03-20
Industry
Chemicals & Pharmaceuticals
Industry rank
#42/168

Data updated August 2026

Subscribe to OLIN Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
100:1
Moderate (Scale: 0–1000:1)
CEO pay
$9.8M
Median worker
$98,383

Answer first

OLIN Corp's FY2025 CEO total of $9.8M ranks #546 of 1,423 complete filings; its 100:1 pay ratio ranks #637. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $98,383. Industry placement uses the FY2025 SIC-28 peer cohort (# 42 of 168, 76th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#546
$9.8M of 1,423 FY2025
Ratio rank
#637
100:1 of 1,423
Industry pct
76th
top quartile of industry peers by pay ratio

How OLIN Corp ranks nationally

OLIN Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$9,798,424 Top 38% higher than 62% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). This entry sits in this band. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

OLIN Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($9.8M) against pay ratio (100:1) for OLIN Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both4408911.510526525.81664414022761754.328879368.538.6:157.1:175.5:193.9:1112.3:1CEO total payPay ratio (CEO : median worker)OLIN Corp, CEO total pay: 9798424 · Pay ratio (CEO : median worker): 100:1OLIN CorpHexcel Corp /de/, CEO total pay: 7252875 · Pay ratio (CEO : median worker): 98:1Hexcel Corp /de/Xencor Inc, CEO total pay: 5521205 · Pay ratio (CEO : median worker): 95:1Xencor IncCogent Biosciences, Inc., CEO total pay: 27767075 · Pay ratio (CEO : median worker): 95:1Cogent Biosciences, Inc.Immunocore Holdings plc, CEO total pay: 10830240 · Pay ratio (CEO : median worker): 92:1Immunocore Holdings plcBiomarin Pharmaceutical Inc, CEO total pay: 21927563 · Pay ratio (CEO : median worker): 109:1Biomarin Pharmaceutical Inc
OLIN Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in OLIN Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · OLIN Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2024–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
100:1
FY2025
vs prior FY
-154:1
from FY2024 254:1
CEO $ YoY
-58%
$9.8M latest
Filings shown
2
FY2024–2025
OLIN Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2024 $23.1M - $90,939 254:1 -
2025 $9.8M -58% $98,383 100:1 -154:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 74303, FY2024–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
100:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$9.8M
Companies in Industry
168
vs. Industry Median
Above
#42 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

OLIN Corp: MID · HEAVY pay ratio

OLIN Corp's FY2025 ratio 100:1 ranks #42 of 168 Chemicals & Pharmaceuticals filers (76th percentile). the CEO earned 100× the median employee ($98,383) in FY2025.

Median employee $98,383 (HIGH-MED); MID · HEAVY stamps put about 100 median-wage years per CEO year.

CEO Total Pay

$9.8M

FY2025 Summary Compensation, above median

Pay Ratio

100:1

Near industry median

OLIN Corp in the higher Chemicals & Pharmaceuticals third

OLIN Corp's FY2025 ratio 100:1 ranks #42 of 168 Chemicals & Pharmaceuticals filers (76th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; OLIN Corp's $9.8M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #546 and ratio rank #637 split - treat 100:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$9.8M
Median Employee Pay
$98,383
Pay Ratio
100:1
Filing Date
2026-03-20

Company Info

Ticker
OLN
CIK
74303
Industry
Chemicals & Pharmaceuticals
SIC Code
2800
State
VA
View SEC filings →
SEC EDGAR DEF 14A for CIK 74303, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. OLIN Corp's FY2025 ratio 100:1 ranks #42 of 168 Chemicals & Pharmaceuticals filers (76th percentile).

Read with OLIN Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · HEAVY · HIGH-MED.

Coinbase Global, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.8M (Δ $10K lighter vs OLIN Corp); MODEST · ELITE-MED vs this page's MID · HEAVY · HIGH-MED.
Lucid Group, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.8M (Δ $30K lighter vs OLIN Corp); MODEST · ELITE-MED vs this page's MID · HEAVY · HIGH-MED.
Advanced Drainage Systems, Inc. · HEAVY

ABS(ceo_total_comp) peer at $9.8M (Δ $36K lighter vs OLIN Corp); MID · HIGH-MED vs this page's MID · HEAVY · HIGH-MED.
Expeditors International Of Washington Inc · HEAVY

ABS(ceo_total_comp) peer at $9.7M (Δ $61K lighter vs OLIN Corp); STEEP · PAR-MED vs this page's MID · HEAVY · HIGH-MED.
Hexcel Corp /de/ (SIC 28 pole)

Hexcel Corp /de/ stamps MID · HEAVY nearest in-SIC by ABS(pay_ratio) to OLIN Corp's MID filing.
National dual ranks · #546/#637

OLIN Corp's FY2025 package sits #546 by CEO dollars and #637 by ratio under HEAVY · MID.
Comp structure · HEAVY

OLIN Corp's HEAVY CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for OLIN Corp (CIK 74303), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.